Cargando…

Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China

The novel coronavirus disease 2019 (COVID-19) was first reported in Wuhan, China, where the initial wave of intense community transmissions was cut short by interventions. Using multiple data sources, here we estimate the disease burden and clinical severity by age of COVID-19 in Wuhan from December...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Juan, Chen, Xinhua, Deng, Xiaowei, Chen, Zhiyuan, Gong, Hui, Yan, Han, Wu, Qianhui, Shi, Huilin, Lai, Shengjie, Ajelli, Marco, Viboud, Cecile, Yu, Prof Hongjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591855/
https://www.ncbi.nlm.nih.gov/pubmed/33110070
http://dx.doi.org/10.1038/s41467-020-19238-2
_version_ 1783601072715071488
author Yang, Juan
Chen, Xinhua
Deng, Xiaowei
Chen, Zhiyuan
Gong, Hui
Yan, Han
Wu, Qianhui
Shi, Huilin
Lai, Shengjie
Ajelli, Marco
Viboud, Cecile
Yu, Prof Hongjie
author_facet Yang, Juan
Chen, Xinhua
Deng, Xiaowei
Chen, Zhiyuan
Gong, Hui
Yan, Han
Wu, Qianhui
Shi, Huilin
Lai, Shengjie
Ajelli, Marco
Viboud, Cecile
Yu, Prof Hongjie
author_sort Yang, Juan
collection PubMed
description The novel coronavirus disease 2019 (COVID-19) was first reported in Wuhan, China, where the initial wave of intense community transmissions was cut short by interventions. Using multiple data sources, here we estimate the disease burden and clinical severity by age of COVID-19 in Wuhan from December 1, 2019 to March 31, 2020. Our estimates account for the sensitivity of the laboratory assays, prospective community screenings, and healthcare seeking behaviors. Rates of symptomatic cases, medical consultations, hospitalizations and deaths were estimated at 796 (95% CI: 703–977), 489 (472–509), 370 (358–384), and 36.2 (35.0–37.3) per 100,000 persons, respectively. The COVID-19 outbreak in Wuhan had a higher burden than the 2009 influenza pandemic or seasonal influenza in terms of hospitalization and mortality rates, and clinical severity was similar to that of the 1918 influenza pandemic. Our comparison puts the COVID-19 pandemic into context and could be helpful to guide intervention strategies and preparedness for the potential resurgence of COVID-19.
format Online
Article
Text
id pubmed-7591855
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-75918552020-11-10 Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China Yang, Juan Chen, Xinhua Deng, Xiaowei Chen, Zhiyuan Gong, Hui Yan, Han Wu, Qianhui Shi, Huilin Lai, Shengjie Ajelli, Marco Viboud, Cecile Yu, Prof Hongjie Nat Commun Article The novel coronavirus disease 2019 (COVID-19) was first reported in Wuhan, China, where the initial wave of intense community transmissions was cut short by interventions. Using multiple data sources, here we estimate the disease burden and clinical severity by age of COVID-19 in Wuhan from December 1, 2019 to March 31, 2020. Our estimates account for the sensitivity of the laboratory assays, prospective community screenings, and healthcare seeking behaviors. Rates of symptomatic cases, medical consultations, hospitalizations and deaths were estimated at 796 (95% CI: 703–977), 489 (472–509), 370 (358–384), and 36.2 (35.0–37.3) per 100,000 persons, respectively. The COVID-19 outbreak in Wuhan had a higher burden than the 2009 influenza pandemic or seasonal influenza in terms of hospitalization and mortality rates, and clinical severity was similar to that of the 1918 influenza pandemic. Our comparison puts the COVID-19 pandemic into context and could be helpful to guide intervention strategies and preparedness for the potential resurgence of COVID-19. Nature Publishing Group UK 2020-10-27 /pmc/articles/PMC7591855/ /pubmed/33110070 http://dx.doi.org/10.1038/s41467-020-19238-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Yang, Juan
Chen, Xinhua
Deng, Xiaowei
Chen, Zhiyuan
Gong, Hui
Yan, Han
Wu, Qianhui
Shi, Huilin
Lai, Shengjie
Ajelli, Marco
Viboud, Cecile
Yu, Prof Hongjie
Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China
title Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China
title_full Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China
title_fullStr Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China
title_full_unstemmed Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China
title_short Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China
title_sort disease burden and clinical severity of the first pandemic wave of covid-19 in wuhan, china
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591855/
https://www.ncbi.nlm.nih.gov/pubmed/33110070
http://dx.doi.org/10.1038/s41467-020-19238-2
work_keys_str_mv AT yangjuan diseaseburdenandclinicalseverityofthefirstpandemicwaveofcovid19inwuhanchina
AT chenxinhua diseaseburdenandclinicalseverityofthefirstpandemicwaveofcovid19inwuhanchina
AT dengxiaowei diseaseburdenandclinicalseverityofthefirstpandemicwaveofcovid19inwuhanchina
AT chenzhiyuan diseaseburdenandclinicalseverityofthefirstpandemicwaveofcovid19inwuhanchina
AT gonghui diseaseburdenandclinicalseverityofthefirstpandemicwaveofcovid19inwuhanchina
AT yanhan diseaseburdenandclinicalseverityofthefirstpandemicwaveofcovid19inwuhanchina
AT wuqianhui diseaseburdenandclinicalseverityofthefirstpandemicwaveofcovid19inwuhanchina
AT shihuilin diseaseburdenandclinicalseverityofthefirstpandemicwaveofcovid19inwuhanchina
AT laishengjie diseaseburdenandclinicalseverityofthefirstpandemicwaveofcovid19inwuhanchina
AT ajellimarco diseaseburdenandclinicalseverityofthefirstpandemicwaveofcovid19inwuhanchina
AT viboudcecile diseaseburdenandclinicalseverityofthefirstpandemicwaveofcovid19inwuhanchina
AT yuprofhongjie diseaseburdenandclinicalseverityofthefirstpandemicwaveofcovid19inwuhanchina